These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33576058)

  • 21. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
    Wahl A; Gralinski LE; Johnson CE; Yao W; Kovarova M; Dinnon KH; Liu H; Madden VJ; Krzystek HM; De C; White KK; Gully K; Schäfer A; Zaman T; Leist SR; Grant PO; Bluemling GR; Kolykhalov AA; Natchus MG; Askin FB; Painter G; Browne EP; Jones CD; Pickles RJ; Baric RS; Garcia JV
    Nature; 2021 Mar; 591(7850):451-457. PubMed ID: 33561864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing.
    Tsuji K; Yamada S; Hirai K; Asakura H; Kanda Y
    J Toxicol Sci; 2021; 46(9):425-435. PubMed ID: 34470994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies.
    Puzyrenko A; Jacobs ER; Sun Y; Felix JC; Sheinin Y; Ge L; Lai S; Dai Q; Gantner BN; Nanchal R; North PE; Simpson PM; Rui H; Benjamin IJ
    Cell Stress Chaperones; 2021 Sep; 26(5):859-868. PubMed ID: 34382151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2-induced disruption of a vascular bed in a microphysiological system caused by type-I interferon from bronchial organoids.
    Fujimoto K; Kameda Y; Nagano Y; Deguchi S; Yamamoto T; Krol RP; Gee P; Matsumura Y; Okamoto T; Nagao M; Takayama K; Yokokawa R
    Lab Chip; 2024 Aug; 24(16):3863-3879. PubMed ID: 38252025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.
    Jacob F; Pather SR; Huang WK; Zhang F; Wong SZH; Zhou H; Cubitt B; Fan W; Chen CZ; Xu M; Pradhan M; Zhang DY; Zheng W; Bang AG; Song H; Carlos de la Torre J; Ming GL
    Cell Stem Cell; 2020 Dec; 27(6):937-950.e9. PubMed ID: 33010822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
    Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
    mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alveolar type II cells and pulmonary surfactant in COVID-19 era.
    Calkovska A; Kolomaznik M; Calkovsky V
    Physiol Res; 2021 Dec; 70(S2):S195-S208. PubMed ID: 34913352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paracrine Regulation of Alveolar Epithelial Damage and Repair Responses by Human Lung-Resident Mesenchymal Stromal Cells.
    Kruk DMLW; Wisman M; Noordhoek JA; Nizamoglu M; Jonker MR; de Bruin HG; Arevalo Gomez K; Ten Hacken NHT; Pouwels SD; Heijink IH
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroinvasion of SARS-CoV-2 in human and mouse brain.
    Song E; Zhang C; Israelow B; Lu-Culligan A; Prado AV; Skriabine S; Lu P; Weizman OE; Liu F; Dai Y; Szigeti-Buck K; Yasumoto Y; Wang G; Castaldi C; Heltke J; Ng E; Wheeler J; Alfajaro MM; Levavasseur E; Fontes B; Ravindra NG; Van Dijk D; Mane S; Gunel M; Ring A; Kazmi SAJ; Zhang K; Wilen CB; Horvath TL; Plu I; Haik S; Thomas JL; Louvi A; Farhadian SF; Huttner A; Seilhean D; Renier N; Bilguvar K; Iwasaki A
    J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33433624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-level alveolar epithelium model for recapitulating SARS-CoV-2 infection and cellular plasticity.
    Yang JW; Lin YR; Chu YL; Chung JHY; Lu HE; Chen GY
    Commun Biol; 2022 Jan; 5(1):70. PubMed ID: 35046486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung Organoids as Model to Study SARS-CoV-2 Infection.
    Peng L; Gao L; Wu X; Fan Y; Liu M; Chen J; Song J; Kong J; Dong Y; Li B; Liu A; Bao F
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection.
    Duan X; Tang X; Nair MS; Zhang T; Qiu Y; Zhang W; Wang P; Huang Y; Xiang J; Wang H; Schwartz RE; Ho DD; Evans T; Chen S
    Cell Rep; 2021 Nov; 37(6):109920. PubMed ID: 34731648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium.
    Schuler BA; Habermann AC; Plosa EJ; Taylor CJ; Jetter C; Negretti NM; Kapp ME; Benjamin JT; Gulleman P; Nichols DS; Braunstein LZ; Hackett A; Koval M; Guttentag SH; Blackwell TS; Webber SA; Banovich NE; ; ; Kropski JA; Sucre JM
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33180746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
    Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
    Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infection.
    Tang X; Xue D; Zhang T; Nilsson-Payant BE; Carrau L; Duan X; Gordillo M; Tan AY; Qiu Y; Xiang J; Schwartz RE; tenOever BR; Evans T; Chen S
    Nat Cell Biol; 2023 Mar; 25(3):381-389. PubMed ID: 36918693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells.
    Calandria JM; Bhattacharjee S; Maness NJ; Kautzmann MI; Asatryan A; Gordon WC; Do KV; Jun B; Mukherjee PK; Petasis NA; Bazan NG
    Sci Rep; 2021 Jun; 11(1):12324. PubMed ID: 34112906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-cell transcriptomic landscape of the lungs of patients with COVID-19.
    Wang S; Yao X; Ma S; Ping Y; Fan Y; Sun S; He Z; Shi Y; Sun L; Xiao S; Song M; Cai J; Li J; Tang R; Zhao L; Wang C; Wang Q; Zhao L; Hu H; Liu X; Sun G; Chen L; Pan G; Chen H; Li Q; Zhang P; Xu Y; Feng H; Zhao GG; Wen T; Yang Y; Huang X; Li W; Liu Z; Wang H; Wu H; Hu B; Ren Y; Zhou Q; Qu J; Zhang W; Liu GH; Bian XW
    Nat Cell Biol; 2021 Dec; 23(12):1314-1328. PubMed ID: 34876692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the Neuropilin-1 receptor with Ovatodiolide and progress in using periodontal ligament organoids for COVID-19 research and therapy.
    Hsieh MS; Chen MY; Chang YS; Huang CS; Hsu TN; Huang MS; Yeh CT; Tzeng YM
    Life Sci; 2024 Aug; 351():122764. PubMed ID: 38838817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
    Bui LT; Winters NI; Chung MI; Joseph C; Gutierrez AJ; Habermann AC; Adams TS; Schupp JC; Poli S; Peter LM; Taylor CJ; Blackburn JB; Richmond BW; Nicholson AG; Rassl D; Wallace WA; Rosas IO; Jenkins RG; Kaminski N; Kropski JA; Banovich NE;
    Nat Commun; 2021 Jul; 12(1):4314. PubMed ID: 34262047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphoproteomics Identifies the Vitamin D Receptor as a Potential Therapeutic Partner in Alveolar Pneumocytes for COVID-19 Infected Patients.
    Brown RE; Wolf DA; Tahseen D
    Ann Clin Lab Sci; 2020 Sep; 50(5):699-700. PubMed ID: 33067219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.